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ABSTRACT 29 
 30 
Maximizing anabolic responses to feeding and exercise is crucial for muscle maintenance and 31 
adaptation to exercise training. We hypothesized that enriching a protein drink with leucine 32 
would improve anabolic responses to resistance exercise (RE: 6×8 knee-extension repetitions 33 
at 75% of 1-RM) in both young and older adults. Groups (n=9) of young (24±6 y, BMI 23±2 34 
kg.m-2) and older men (70±5 y, BMI 25±2 kg.m-2) were randomized to either: (i) RE 35 
followed by Slim-Fast Optima (SFO 10 g PRO; 24 g CHO) with 4.2 g of leucine (LEU) or, 36 
(ii) RE+SFO with 4.2 g of alanine (ALA; isonitrogenous control). Muscle biopsies were 37 
taken before, immediately after, and 1, 2 and 4 h after RE and feeding. Muscle protein 38 
synthesis (MPS) was measured by incorporation of [1, 2-13C2] leucine into myofibrillar 39 
proteins and the phosphorylation of p70S6K1 by immunoblotting. In young men, both area 40 
under the curve (AUC; FSR 0-4 h P<0.05) and peak FSR (0.11 vs. 0.08%.h.-1; P<0.05) were 41 
greater in the SFO+LEU than in the SFO+ALA group, after RE. Similarly, in older men, 42 
AUC analysis revealed that post-exercise anabolic responses were greater in the SFO+LEU 43 
than SFO+ALA group, after RE (AUC; FSR 0-4 h P<0.05). Irrespective of age, increases in 44 
p70S6K1 phosphorylation were evident in response to both SFO+LEU and SFO+ALA, 45 
although greater with leucine supplementation than alanine (fold-change 2.2 vs. 3.2; P<0.05), 46 
specifically in the older men. We conclude that addition of Leucine to a sub-maximal PRO 47 
bolus improves anabolic responses to RE in young and older men. 48 
 49 
 50 
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INTRODUCTION 52 
 53 
Ingestion of protein at rest (1) or after resistance exercise (RE) (2) stimulates muscle protein 54 
synthesis (MPS) through anabolic signaling (mechanistic target of rapamycin (mTOR) 55 
signaling pathway) in both young and elderly muscle (3,4). However, synthetic responses 56 
after acute resistance exercise in fasted (4) and postprandial states (5) and in response to 57 
feeding alone (6–9) have been shown to be blunted in older age. Since basal muscle protein 58 
turnover in the post-absorptive condition in healthy old people is found to be similar to rates 59 
in young muscle (6,9) these blunted responses of elderly muscle seem to be key factors in the 60 
aetiology of their gradual age related muscle loss and would thus be a target for intervention 61 
to prevent or slow the progression of sarcopenia.   62 
 63 
Post-exercise ingestion of nutrients (protein and essential amino acids (EAA) with or without 64 
CHO) has been shown to elevate MPS above that measured following RE alone in both young  65 
(10–12) and elderly individuals (3,13) primarily due to EAA (14–16) and particularly leucine 66 
(17,18) (at least in young individuals). Although leucine, and other EAA (19) have been 67 
shown to stimulate MPS in humans acutely over 90 min, it is unlikely that this anabolic effect 68 
would be sustainable without provision of other EAA which would become limiting for MPS; 69 
clearly this is not a viable long term strategy to promote MPS and muscle growth, but it may 70 
provide a route by which MPS can be maximised when protein intake is low or insufficient to 71 
maximally stimulate MPS i.e. less than 20g in any meal.  Furthermore, recent studies have 72 
shown, that the attenuated muscle protein synthetic and anabolic signalling responses to food 73 
intake in the elderly, can be compensated by increasing the leucine concentration of a meal in 74 
resting state (8,20). However, Dickinson and colleagues demonstrated that MPS following 75 
RE was maximally stimulated with 20 g EAA (containing 1.85 g Leu), and further 76 
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supplementation with Leucine to 3.5 g could not further stimulate MPS (21).  We have also 77 
recently demonstrated in elderly women that a low dose leucine enriched EAA mix (3g EAA, 78 
1.2g leucine), was as effective as 20 g Whey protein in extending the stimulation of MPS 79 
following RE (22), suggesting there is a ceiling beyond which adding leucine is ineffectual. 80 
In contrast however, Yang et al showed a clear dose response of MPS to RE with increasing 81 
amounts of whey protein (up to 40 g, equivalent to approx. 1g of leucine for every 10 g of 82 
Whey) (13), indicating there was no maximum response. Despite this spurious data, it seems 83 
that the ingestion of leucine enriched EAA/ protein supplements following E may provide 84 
an effective strategy to improve post-exercise MPS in the elderly, without the need for 85 
ingesting overly large amounts of protein. 86 
Therefore, the goal of the present study was to assess the impact of leucine and sub-maximal 87 
protein ingestion using a meal replacement strategy i.e. Slimfast Optima, after an acute bout 88 
of resistance exercise on muscle protein synthesis (MPS) and anabolic signalling, particularly 89 
activation of mTOR signalling pathway, in young and older muscle. We hypothesised that 90 
enriching a sub-maximal protein feed, i.e. 10g with leucine shortly after a bout of RE would 91 
enhance anabolic responses in elderly men. 92 
 93 
METHODS 94 
 95 
Subject Recruitment and screening 96 
The study was approved by the University of Nottingham Ethics Committee and complied 97 
with the Declaration of Helsinki. Written informed consent was obtained from the volunteers 98 
following explanation of the study protocol and procedures and any associated risks. Groups 99 
of 27 young and 27 older men were recruited for the exercise ± nutritional intervention 100 
studies (Subject Characteristics, see Table 1). All our recruits were physically independent 101 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
                                                                        Leucine enhances response to exercise in ageing 
 
 5
and healthy. Screening procedures included a clinical history, physical examination, 102 
electrocardiogram, by a qualified physician. In addition a full blood count, coagulation 103 
profile, fasting blood glucose, and markers of liver, kidney, and thyroid function were 104 
assessed. Subjects were excluded if they had a history of metabolic disease (e.g. diabetes, 105 
thyroid disorders, obesity, anaemia, cancer) and any of the following cardiac, pulmonary, 106 
liver, kidney, vascular (including clotting) disorders, and poorly controlled hypertension; also 107 
excluded were those who showed evidence of alcohol abuse, palpable muscle wasting, 108 
corticosteroid use or the inability to discontinue aspirin therapy. Older subjects with mild 109 
controlled hypertension (<140/90 mm Hg) were admitted to the study, but refrained from 110 
taking medication on the study day. 111 
 112 
For subjects passing screening procedures, we measured the maximal strength of the 113 
dominant leg on a leg extension machine (ISO leg extension, Leisure Lines (GB) Ltd) and 114 
they underwent a familiarization protocol of the exercise regime. Body composition, i.e. lean 115 
body mass, was assessed by dual-energy X-ray absorptiometry (DXA; GE Lunar Prodigy II, 116 
GE Healthcare).  117 
 118 
Study design and optimization of feeding timing 119 
Preliminary studies were undertaken to: (i) determine the time-course of the rise in blood AA 120 
after consumption of a can of SlimFast Optima, and particularly the timing of the peak AA 121 
concentration; (ii) determination of the time-course of the rise of leucine concentration in the 122 
blood after consuming gelatine capsules containing 4.2 g of leucine; (iii) adjusting the timing 123 
of ingestion of the leucine capsule in relation to the SlimFast Optima, to ensure the peak AA 124 
concentration coincided, thereby determining the post-exercise feeding schedule. This 125 
approach was chosen in order to synchronize the appearance of peak AA, which would be 126 
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determined by digestion, gut transport and splanchnic metabolism – rather than exercise 127 
conditions – hence we did this simply under resting conditions in a small number of subjects.  128 
 129 
These were performed on 3 young volunteers, who took part in all three studies. In each case 130 
an 18 g cannula was inserted into an antecubital vein of the postabsorptive volunteer and a 131 
blood sample was taken before subjects ingested either, (i) a full can (325ml) of SlimFast 132 
Optima; or (ii) 4.2 g of leucine alone; finally 4.2 g leucine was given followed by SlimFast 133 
Optima 30 min later (estimated from the difference in peak AA concentrations from i and ii) 134 
to confirm coincident appearance in the blood.  Blood was sampled over 2.5 h at 20 min 135 
intervals into Lithium-Heparin tubes and plasma separated immediately and analyzed for AA 136 
(Figure 2) using an ion-exchange AA analyser (Biochrom 30, Biochrom Ltd, Cambridge).  137 
 138 
For the principal studies, three groups each (n=9) of young and old were randomly assigned 139 
to: (i) RE + 325 ml SlimFast Optima (SFO) with 4.2 g of Leucine (LEU) (SFO+LEU), or (ii) 140 
RE+SFO with 4.2 g of alanine (ALA) (SFO+ALA) as control. All subjects performed 6 sets 141 
of 8 repetitions of an isotonic, full cycle unilateral leg extension and flexion exercise at 75% 142 
of 1 RM. Each subject received a full can (325 ml) of SlimFast Optima (10 g PRO + 24 g 143 
CHO; protein and AA composition: 8g casein, 2g whey, 0.05g soy, 0.95 g leucine, 0.30 g 144 
alanine, 0.36 g isoleucine and 0.76 g valine) and 4.2 g of leucine or alanine (the latter as an 145 
isonitrogenous control for the leucine) capsules. We purposely decided to give SFO 146 
containing a sub-maximal dose of protein i.e. 10g, (~4.5 g of EAA) to our subjects in both the 147 
leucine and alanine groups following the resistance exercise to demonstrate the efficacy of 148 
adding leucine; also since Moore et al., have recently shown in healthy young men that 149 
ingestion of 20 g intact protein (or about 8.6 g EAAs as in the SFO+LEU group) is sufficient 150 
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to maximally stimulate MPS (1); we gave a sub-maximal dose in order to observe an increase 151 
in response to added leucine or alanine.  152 
  153 
Acute study Protocol 154 
Subjects reported to the laboratory after an overnight fast, having refrained from any intense 155 
exercise for at least 72 h. At ~ 0900 h, subjects had catheters (18G) inserted in the antecubital 156 
veins of both arms, one for tracer infusion and one for venous blood sampling. A primed, 157 
continuous infusion (0.7 mg.kg-1, 1 mg.kg.h-1) of leucine tracer (99 Atoms % of [1, 2-13C2], 158 
Cambridge Isotopes Limited, Cambridge, MA, USA) was then initiated (at 0 h) immediately 159 
after the first biopsy and continued for 7 h. After taking biopsies at rest at 0 and 2.5 h in the 160 
post-absorptive pre-exercise state, the subjects performed 6 sets of unilateral leg extensions at 161 
a moderate contraction velocity (1-2 s concentric, 1-2 s eccentric) and 75%of 1-RM, with 162 
three min rest in between sets. After RE, each subject took first 4.2 g of alanine or leucine 163 
capsules and then SFO 30 min later (on the basis of feeding optimization studies described 164 
below, to ensure peak appearance coincided). Subjects in the rest group first took 4.2 g of 165 
leucine capsules and then SFO at 30 min following their 2nd muscle biopsy. Muscle biopsies 166 
were taken under sterile conditions from the m. vastus lateralis under local anaesthesia (1% 167 
lignocaine) using our standard conchotome technique. The muscle tissue was washed in ice 168 
cold saline to remove excess blood, and dissected free of visible fat and connective tissue, 169 
then snap frozen in liquid nitrogen and stored at -80°C prior to analysis. After the study, 170 
cannulae were removed; the subjects were fed and assessed for 30 min before being escorted 171 
home. The protocol scheme is shown in figure 1. 172 
 173 
Muscle preparation for MPS analysis 174 
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Muscle tissue (~ 25 mg) was snipped with scissors in ice cold homogenization buffer (50 mM 175 
Tris HCl (pH 7.4), 1 mM EGTA, 1 mM EDTA, 10 mM β-glycerophosphate; all Sigma-176 
Aldrich, Poole, UK) including protease inhibitors (Roche, West Sussex, UK). The 177 
homogenate was centrifuged at 3,000 g for 20 min to precipitate the myofibrillar fraction, the 178 
supernatant removed for western analyses, and the pellet was then solubilized with 0.3 M 179 
NaOH and centrifuged at 3,000 g for 20 min to pellet the insoluble collagen fraction. The 180 
solubilized myofibrillar protein was precipitated with ice cold 1M PCA, washed twice with 181 
70% ethanol, to ensure free amino acids were removed, and collected by centrifugation. The 182 
Myofibrillar protein bound amino acids were subsequently released by acid hydrolysis in 183 
Dowex H+ resin slurry (0.05M HCl) at 110°C overnight. The amino acids were then 184 
derivatized as their n-acetyl-N-propyl esters (23). The enrichment of [1, 2-13C2] leucine 185 
incorporated into protein was then measured by gas chromatography- combustion-isotope 186 
ratio mass spectrometry (Delta plus XP, Thermofisher Scientific, Hemel Hempstead,UK) 187 
using our standard techniques (24). The fractional synthetic rate (FSR) of the myofibrillar 188 
fraction was calculated from the incorporation of [1,2 13C2] leucine, using venous plasma 189 
KIC labelling between muscle biopsies to represent the immediate precursor for protein 190 
synthesis as previously described (17,18); using the standard precursor-product method: 191 
fractional protein synthesis (ks, %·h–1) = Em/Ep × 1/t × 100, where Em is the change in 192 
protein labelling between two biopsy samples, Ep is the mean value over time of venous -193 
KIC, and t is the time between biopsies in hours.  194 
Immunoblotting 195 
Phosphorylated protein concentrations of p70 ribosomal S6 kinaseThr389  (p70S6K1) was 196 
determined using our standard methods as previously described (24). After homogenising the 197 
muscle tissue the sarcoplasmic protein fraction was separated from the myofibrillar fraction 198 
by centrifugation at 3,000 × g. Proteins were solubilised in Laemmli buffer prior to 199 
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separation by electrophoresis at 200 V. h-1, then transferred to 100 % methanol permeabilized 200 
0.2 mm PVDF membranes at 100 V over 45 minutes. Membranes were blocked in 5% BSA 201 
solution for 60 min before overnight exposure at 4°C to p70S6K1Thr389 primary antibody 202 
(Abcam) diluted 1:2000. The next morning membranes were incubated with anti-rabbit IgG 203 
secondary at 1:2000 for 1 h before quantification using a Chemidoc XRS system (Bio-Rad 204 
Laboratories, Inc. Hercules, CA).  205 
 206 
Statistical analysis 207 
All data are shown as means ± standard error of mean (SEM). Area under the curve for MPS 208 
and p70S6K1 data was analysed as above baseline. Statistical Analyses were made using 209 
GraphPad Prism (Graph Pad software, version 5.0, La Jolla, CA, USA). Two-way ANOVA 210 
with Bonferroni post hoc test and Student’s t-test were used to identify statistical differences 211 
as a result of age and treatment. Significance was accepted as P <0.05.  212 
 213 
RESULTS 214 
Plasma amino acid concentrations 215 
The results clearly show higher plasma essential amino acid concentrations after SFO in all 216 
groups following the resistance exercise, which was further significantly enhanced with the 217 
addition of leucine in both groups and the time course of this rise was similar in both young 218 
and older group. Thus we achieved the aim of increasing the availability of leucine, as a 219 
prerequisite to testing the hypothesis that it would improve the metabolic responses of MPS 220 
and cell anabolic signalling after resistance exercise.  221 
 222 
Myofibrillar protein synthesis (MPS) and p70S6K1 phosphorylation 223 
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On examination of the responses of MPS (Fig 4): 1) in young men, SFO+LEU stimulated 224 
(P<0.05) MPS more than SFO+ALA (AUC; 0.15±0.01 vs. 0.12±0.01 %.4h.-1 FSR 0-4 h 225 
P<0.05) and peak FSR at 2h (0.11±0.008  vs. 0.08±0.008 %.h.-1; P<0.05); 2) in older men, 226 
SFO+LEU stimulated MPS more than SFO+ALA (AUC: O 0.14±0.01 vs. 0.11±0.01 %.4h.-1, 227 
P<0.05); 3) in older men, MPS following SFO+LEU didn’t return to baseline at 4 h as seen in 228 
other groups therefore the net positive balance (effect of feeding over ex alone) was probably 229 
even greater as it lasted beyond the 4h. SFO supplemented with leucine enhanced p70S6K1 230 
phosphorylation in the older (P<0.05) but not younger men. Under exercised conditions, 231 
there were no age-related differences when comparing overall anabolic responses (i.e. net 232 
MPS over the 4 h measurement period) in response to SFO+LEU or SFO+ALA.  233 
 234 
DISCUSSION 235 
 236 
This study has provided novel information, that it is possible to further enhance MPS by 237 
giving leucine enriched suboptimal protein supplementation immediately after exercise. 238 
Specifically, ingestion of 325 ml of CHO + PRO drink containing 5.2 g of leucine in total 239 
(i.e. ~1g from protein plus 4.2 g in capsules) immediately after an acute bout of RE at 75% 240 
1RM markedly enhanced MPS and p70S6K1 responses of the older men such that their rates 241 
were similar to those of the young. We purposely provided SFO containing ~4.5 g of EAA to 242 
our subjects in both leucine and alanine groups following the resistance exercise as it was 243 
recently shown that ingestion of 20 g intact protein (~8.6 g EAA) was sufficient to stimulate 244 
MPS maximally (1). Thus we expected therefore, that addition of free-leucine to 10 g whole 245 
protein would have an additive effect on MPS. 246 
Indeed, several studies have highlighted the importance of combining RE and AA 247 
supplementation to maximize the MPS response and shown that consuming essential amino 248 
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acids (25) or leucine-enriched EAA after RE augments the contraction induced increase in 249 
MPS (26). For example, Dreyer et al. recently showed that leucine-enriched EAA+CHO 250 
ingestion following an acute bout of RE enhanced mTOR signaling and MPS in young human 251 
subjects when compared to those following exercise without nutrition (26). More recently 252 
supplementation of 6.25g of whey protein with either Leu (2.25g) or an EAA mix with no 253 
added leucine have been shown to stimulate MPS following RE (14). However, only young 254 
men were studied. Thus, to our knowledge, this is the first study reporting a comparison of 255 
the time-course of changes in MPS and p70S6K1 responses after RE and the provision of 256 
leucine in both young and old men to a suboptimal dose of protein.  257 
Data surrounding leucine supplements have yielded contrasting results. Recently, Katsanos et 258 
al. demonstrated that ingestion of 6.7 g of an EAA mix containing 41% leucine (1.7 g over a 259 
3.5 h period) stimulated MPS rates in the elderly to a greater extent than an EAA mixture 260 
with only 26% leucine, producing similar synthetic responses to those seen in young muscle 261 
(8). Similarly Rieu et al. showed that co-ingestion of leucine with protein, carbohydrate and 262 
fat administered as small meals (50ml every 20 min, a total of 3g Leu) over a 5 h period 263 
improved MPS in elderly men in the rested state (20). This supports our present findings and 264 
indicates that leucine should represent a high proportion of dietary protein intake and post-265 
exercise supplementation to maximally stimulate MPS. Although it should also be noted that 266 
supplementation of a small dose of whey (6.25g) with an EAA mix containing no additional 267 
Leu yielded an improvement in MPS similar to a whey plus leucine  (2.25 g) only group (14).  268 
Which supports previous findings of ours suggesting that EAA other than leucine i.e. 269 
phenylalanine valine and threonine are also capable of promoting MPS acutely and anabolic 270 
signalling when administered as a large bolus (19,27), suggesting the recently proposed 271 
“leucine trigger” hypothesis (28) needs to be revised. 272 
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On the other hand, the present data is in contrast with recently published study by Koopman 273 
(29), who showed that co ingestion of leucine with carbohydrate and protein (4.7 g leucine 274 
vs.17.6 g leucine over a 6h period) following physical activity did not further elevate MPS in 275 
elderly men, despite whole body protein balance being 2.8% greater (p<0.05) in the higher 276 
leucine group. The apparent discrepancy is likely explained by the fact that in the present 277 
study, post-exercise MPS responses following the RE and nutritional supplementation were 278 
measured at regular intervals (at 1, 2 and 4 h) during the post-exercise period, where MPS 279 
rates showed a faster rise and peaked over the 1-2 h post exercise before showing a 280 
downwards towards trend at 2-4 h. However, in Koopmans study, MPS was measured only at 281 
6h post exercise, thereby missing this peak of MPS rise, perhaps giving the reported 282 
indistinguishable MPS responses. This highlights the on/off nature of MPS, and thus 283 
importance of temporal data gathering over short periods in determining cause and effect 284 
related to interventional strategies (24,30,31). It seems to us that there is a clear dose response 285 
of MPS to protein, EAA or Leu ingestion (6,13,32), and that although the duration of the 286 
stimulation is extended by prior exercise, there is a maximal response to providing additional 287 
amino acid substrate, of around 10g of EAA, 20g Whey or 3g of leucine.  There are a number 288 
of studies that demonstrate, in both the fed only (8,32) and fed plus exercised condition 289 
(21,29), that providing additional leucine has no further impact upon MPS; an exception to 290 
this being the study of Yang et al, who although they show a maximal ie saturable MPS 291 
response to whey protein feeding alone i.e. MPS is the same at 20 and 40g, MPS continues to 292 
significantly increase following RE with increasing doses of whey in elderly men (13).   293 
 294 
Regarding signalling proteins, it has been shown that the leucine supplementation in resting 295 
conditions as well as following resistance exercise enhance MPS via activating insulin-296 
dependent and as well as insulin-independent mTOR pathway signalling proteins (3,18,33). 297 
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Correspondingly, we saw quantitatively similar increases in p70S6K1 phosphorylation, a 298 
robust proxy for mTORc1 anabolic signalling (4,18), which were maximal 2 h post-exercise 299 
+ nutritional supplementation in all groups, however it was significantly enhanced (P<0.05) 300 
in old SFO+LEU group. This enhanced response of p70S6K1 in old SFO+LEU group could 301 
explain their greater increase in myofibrillar protein synthesis, when compared to the 302 
isonitrogenous alanine control. Finally, it should be pointed out that cell signals do not 303 
always match with MPS such that tying cause and effect is limited (24). Moreover, signaling 304 
responses are complex and involve many signals outside of those we have looked at and 305 
which could be important in regulating the heightened response in MPS we see when 306 
providing a leucine-enriched meal supplement, e.g. the leucine senor Sestrin 2 (34). Future 307 
work should hone in on such mechanisms.  308 
Despite demonstrating a blunted response of myofibrillar protein synthesis to exercise in the 309 
elderly in postabsorptive state (4), we saw no differences between MPS responses to feeding 310 
plus RE between the young and elderly subjects.  This lack of an obvious “blunted” response 311 
has been observed previously at low levels of protein or EAA feeding (6) and may represent 312 
an analytical limitation of the technique in detecting small differences between the groups. 313 
Despite this, in the present study, we observed an enhanced MPS response in old SFO+LEU 314 
group, identical to those seen in young, and interestingly MPS was still elevated at 4h after 315 
the exercise, thus highlighting the potential of combining RE with leucine enriched 316 
supplementation to maximise the anabolic responses. It would be a key next step to combine 317 
the anabolic influence of RE and ingestion of a amino acid source enriched with leucine over 318 
longer periods i.e. in order to determine if longer term supplements can increase clinically 319 
important aspects of muscle mass and muscle function in older individuals. Indeed, initial 320 
studies are in support of this notion, with one study showing that leucine enriched 321 
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supplements show improvements indices of muscle mass/function, supporting this notion 322 
(35). Perhaps our study highlights potential mechanisms underlying this.  323 
 324 
 In conclusion, this study shows that it is possible to enhance MPS and p70S6K1 responses in 325 
young and older men by giving leucine enriched sub-optimal protein supplement immediately 326 
after exercise.   327 
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 493 
Table 1 Subjects’ characteristics (mean±SEM) 494 
 Young men (n =27) Older men (n=27) 
Age (y) 24±6 70±5* 
Weight (kg) 75±10 76±10 
Height (m)  1.79±0.05 1.74±0.05 
BMI (kg.m2) 23±2 25±2 
Lean Mass (kg) 59±7 54±4 
Fat mass (kg) 13±5 19±8 
% Body fat  17±6 25±9 
1 repetition maximum (RM) (N) 683±171 392±111*  
Blood glucose (mM) overnight fasted 4.6±0.5 5.0±0.4 
* Significant difference between groups P<0.05 495 
 496 
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Figure 1 504 
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Figure 2 519 
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Figure 3 526 
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Figure 4 534 
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Figure 5 543 
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FIGURE LEGENDS 546 
 547 
Figure 1. Study protocol for the measurement of myofibrillar protein synthesis and muscle 548 
anabolic signalling phosphorylation to unilateral leg extension exercise at 75% 1RM 549 
followed by the ingestion of Slim-Fast Optima (SFO) with 4.2 g leucine or alanine in post-550 
absorptive young and older men (n=9). NB 9 older men were studied at rest consuming SFO 551 
and 4.2g leucine without exercise. 552 
 553 
Figure 2.  Concentrations of essential amino acids (total or with leucine subtracted) or 554 
leucine in plasma after drinking 325 ml of SlimFast Optima with (A) or without (B) 4.2g of 555 
leucine taken in a gelatine capsule 30 min before the SlimFast Optima. Values are 556 
means±SEM for n = 3.  In some cases the error bars are within the symbols.  557 
 558 
Figure 3. Plasma essential amino acid concentrations after 6×8 repetitions unilateral leg 559 
extension exercise at 75% 1RM in older and young men (RT) after SlimFast Optima 560 
supplemented with leucine (RT+SFO+Leu) (A) or alanine (RT+SFO+Ala) (B). 561 
 562 
Figure 4. Responses of myofibrillar protein synthesis to resistance exercise in older men with 563 
or without SlimFast Optima plus leucine or alanine (control) and in young men after 564 
resistance exercise with SlimFast Optima +leucine or alanine.   565 
 566 
Figure 5.  Responses of p70S6K11 phosphorylation to resistance exercise in older men with 567 
or without SlimFast Optima plus leucine or alanine (control) and in young men after 568 
resistance exercise with SlimFast Optima +leucine or alanine. 569 
